Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · IEX Real-Time Price · USD
12.09
-0.08 (-0.66%)
Jul 2, 2024, 4:30 PM EDT - Market closed

Mineralys Therapeutics Market Cap

Mineralys Therapeutics has a market cap or net worth of $600.25 million as of July 2, 2024. Its market cap has decreased by -3.98% in one year.

Market Cap
600.25M
Enterprise Value
261.69M
1-Year Change
-3.98%
Ranking
Category
Stock Price
$12.09

Market Cap Chart

Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has decreased from $624.91M to $600.25M, a decrease of -3.95%. That is a compound annual growth rate of -2.85%.

History

DateMarket Cap% Change
Jul 2, 2024600.30M69.82%
Dec 29, 2023353.50M-43.43%
Feb 10, 2023624.91M-
View and export this data all the way back to 2023. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Surmodics 599.49M
PureTech Health 598.30M
Cassava Sciences 592.51M
Fulgent Genetics 587.11M
Arbutus Biopharma 583.14M
REGENXBIO 576.30M
Celcuity 574.96M
Humacyte 571.60M
Market Cap Rankings